Jinju, South Korea

Minn Sohn

This inventor holds 6 USPTO granted patents and 3 published patent applications. Top assignees: Lactomason Co., Ltd., Binggrae Co., Ltd., Korea Research Institute of Bioscience and Biotechnology. Active years: 2023-2026.

USPTO Granted Patents = 6 

% Patents Active = 16.7

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Minn Sohn

Introduction

Minn Sohn is a notable inventor based in Jinju-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the preparation of lactic acid bacteria. His innovative methods have the potential to impact various applications in food science and health.

Latest Patents

Minn Sohn holds a patent for a "Method for preparing highly concentrated killed bacteria using membrane filter and killed bacteria prepared thereby." This patent describes a method for preparing killed lactic acid bacteria using a bioreactor that includes a culture device and a membrane filter. The process aims to enhance the efficiency of producing killed bacteria, which can be utilized in various applications.

Career Highlights

Throughout his career, Minn Sohn has demonstrated a commitment to advancing biotechnological methods. His work at Lactomason Co., Ltd. has allowed him to explore innovative solutions in the field. With 1 patent to his name, he continues to contribute to the scientific community.

Collaborations

Minn Sohn has collaborated with talented individuals such as Il Seon Jung and Jong Bin Yun. These partnerships have fostered a creative environment that encourages innovation and the development of new technologies.

Conclusion

Minn Sohn's contributions to biotechnology, particularly in the preparation of lactic acid bacteria, highlight his role as an influential inventor. His work not only advances scientific knowledge but also has practical implications for various industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…